SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort

A range of studies globally demonstrate that the effectiveness of SARS-CoV-2 vaccines wane over time, but the total effect of anti-S antibody levels on risk of SARS-CoV-2 infection and whether this varies by vaccine type is not well understood. Here we show that anti-S levels peak three to four week...

Descripción completa

Detalles Bibliográficos
Autores principales: Aldridge, Robert W., Yavlinsky, Alexei, Nguyen, Vincent, Eyre, Max T., Shrotri, Madhumita, Navaratnam, Annalan M. D., Beale, Sarah, Braithwaite, Isobel, Byrne, Thomas, Kovar, Jana, Fragaszy, Ellen, Fong, Wing Lam Erica, Geismar, Cyril, Patel, Parth, Rodger, Alison, Johnson, Anne M., Hayward, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387883/
https://www.ncbi.nlm.nih.gov/pubmed/35982056
http://dx.doi.org/10.1038/s41467-022-32265-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387883/
https://www.ncbi.nlm.nih.gov/pubmed/35982056
http://dx.doi.org/10.1038/s41467-022-32265-5

Ejemplares similares